Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2

Maya F. Amjadi, Sarah E. O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep R. Narpala, Peter J. Halfmann, S. Janna Bashar, Christopher R. Glover, Anna S. Heffron, Alison Taylor, Britta Flach, David H. O’Connor, Yoshihiro Kawaoka, Adrian B. McDermott, Ajay K. Sethi, Miriam A. Shelef
doi: https://doi.org/10.1101/2021.01.05.21249240
Maya F. Amjadi
1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah E. O’Connell
2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tammy Armbrust
3Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI 53711 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aisha M. Mergaert
1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
4Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandeep R. Narpala
2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Halfmann
3Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI 53711 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Janna Bashar
1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher R. Glover
1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna S. Heffron
4Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alison Taylor
2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Britta Flach
2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David H. O’Connor
4Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Kawaoka
3Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI 53711 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian B. McDermott
2Vaccine Immunology Program, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ajay K. Sethi
5Department of Population Health Sciences, University of Wisconsin-Madison, Madison, WI 53726 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miriam A. Shelef
1Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705 USA
6William S. Middleton Memorial Veterans Hospital, Madison, WI 53705 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mshelef@medicine.wisc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Lasting immunity will be critical for overcoming the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, factors that drive the development of high titers of anti-SARS-CoV-2 antibodies and how long those antibodies persist remain unclear. Our objective was to comprehensively evaluate anti-SARS-CoV-2 antibodies in a clinically diverse COVID-19 convalescent cohort at defined time points to determine if anti-SARS-CoV-2 antibodies persist and to identify clinical and demographic factors that correlate with high titers. Using a novel multiplex assay to quantify IgG against four SARS-CoV-2 antigens, a receptor binding domain-angiotensin converting enzyme 2 inhibition assay, and a SARS-CoV-2 neutralization assay, we found that 98% of COVID-19 convalescent subjects had anti-SARS-CoV-2 antibodies five weeks after symptom resolution (n=113). Further, antibody levels did not decline three months after symptom resolution (n=79). As expected, greater disease severity, older age, male sex, obesity, and higher Charlson Comorbidity Index score correlated with increased anti-SARS-CoV-2 antibody levels. We demonstrated for the first time that COVID-19 symptoms, namely fever, abdominal pain, diarrhea and low appetite, correlated consistently with higher anti-SARS-CoV-2 antibody levels. Our results provide new insights into the development and persistence of anti-SARS-CoV-2 antibodies.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project was funded through a COVID-19 Response grant from the Wisconsin Partnership Program and a pilot award from the Department of Medicine both at the University of Wisconsin School of Medicine and Public Health to M.A.S. Additional support was provided by the National Institutes of Health National Institute on Aging to M.F.A. (T32 AG000213), National Heart, Lung, and Blood Institute (T32 HL007899) to A.M.M., and National Institute of Allergy and Infectious Disease to A.S.H. (T32 AI007414).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Human studies were performed according to the Declaration of Helsinki and were approved by the Institutional Review Board at the UW-Madison. Written informed consent was received from participants prior to inclusion in the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of interest statement: The authors have declared that no conflict of interest exists.

Data Availability

Data will be provided upon reasonable request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 06, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2
Maya F. Amjadi, Sarah E. O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep R. Narpala, Peter J. Halfmann, S. Janna Bashar, Christopher R. Glover, Anna S. Heffron, Alison Taylor, Britta Flach, David H. O’Connor, Yoshihiro Kawaoka, Adrian B. McDermott, Ajay K. Sethi, Miriam A. Shelef
medRxiv 2021.01.05.21249240; doi: https://doi.org/10.1101/2021.01.05.21249240
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Fever, Diarrhea, and Severe Disease Correlate with High Persistent Antibody Levels against SARS-CoV-2
Maya F. Amjadi, Sarah E. O’Connell, Tammy Armbrust, Aisha M. Mergaert, Sandeep R. Narpala, Peter J. Halfmann, S. Janna Bashar, Christopher R. Glover, Anna S. Heffron, Alison Taylor, Britta Flach, David H. O’Connor, Yoshihiro Kawaoka, Adrian B. McDermott, Ajay K. Sethi, Miriam A. Shelef
medRxiv 2021.01.05.21249240; doi: https://doi.org/10.1101/2021.01.05.21249240

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8557)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1749)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10292)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (249)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3835)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (166)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)